ANN ARBOR ? The MichBio Expo Sept. 29 was the coming out party for a new Michigan biopharmaceutical company that hopes to commercialize research developed by a University of Michigan geneticist that might cure a fatal lung disease that kills 40,000 people in the United States each year ? the same number killed annually by
ANN ARBOR - MichBio has announced five finalists for the Pfizer Research Contract Competition, with up to three finalists winning funding for their research proposals from Pfizer, Michigan?s largest life sciences company. This competition is part of a larger effort by Pfizer to promote partnerships and accelerate business development in the life sciences in Michigan
ANN ARBOR ? The University of Michigan will build a $10.5 million interdisciplinary center for stem cell research, which will be based at the university?s Life Science Institute. The center for stem cell biology will be established with funding provided by the U-M Medical School, the Life Sciences Institute and the Molecular and Behavioral Neuroscience
ANN ARBOR ? Roger Newton, who sold his drug development company two years ago to Pfizer for $1.3 billion, will deliver the keynote speech at MichBio?s Student Career Day Sept. 28 at Wayne State University. Newton will moderate a panel of drug discovery scientists who will take students through the process of developing a medication
KALAMAZOO ? Some $4 billion in cuts by Pfizer, Michigan?s largest drug development company, could eliminate jobs in both Kalamazoo and Ann Arbor, where the company operates major R&D centers. Pfizer employs about 5,200 people in Kalamazoo County, where it has operations in research, manufacturing and animal-health in Kalamazoo, Portage and Richland Township. Another 2,600
DETROIT - Early registration for the MichBio Expo 2005 opened Monday. The Expo is MichBio?s daylong event for professionals from across the life sciences spectrum and at every stage of business development, which will be held Sept. 29 at the Cobo Exhibition and Conference Center in downtown Detroit. The event features a life sciences conference
LANSING - As the embryonic stem cell research bills from Rep. Andy Meisner (D-Ferndale) prepare to wind through the Legislature, lawmakers in other states and Congress are also drafting laws of their own that would fund the controversial medical practice that would be used to advance life sciences. Although the debate over embryonic stem cell
GRAND RAPIDS ? The Van Andel Tuesday unveiled plans for a $150 million expansion of its medical research and education complex in downtown Grand Rapids in the heart of the city?s health-care district. Ground will be broken next spring on the 280,000 square foot addition to the west side of the original 186,000 square foot
DETROIT ? It?s not often that a Michigan life sciences company gets mentioned as one of the best in the world. But such kudos increasingly are going to Asterand, a human tissue and blood bank for commercial and academic research. The company was co-founded five years ago by Randal Charlton, the current chairman of MichBio,
ANN ARBOR ? The impact of Pfizer Inc.?s $1.3 billion acquisition of Esperion Therapeutics continues to be felt in the Michigan life sciences industry a year after the deal closed. The incredibly lucrative Esperion exit was by far the biggest for any Michigan technology company this far, providing the state with a poster child to